University of North Texas Health Science Center

Fort Worth, Texas 76109

3 studies enrolling now · 52 studies all time

What they study most

Aging Well, Alzheimer Disease, Alzheimer's Disease, Cancer, Carotid Atherosclerosis, Cerebrovascular Disease, Cerebrovascular Disorders, Chronic Low Back Pain, Chronic Sinusitis, Cognitive Decline, Depression, Diabetes

Studies at this site

• IHT for Mild Cognitive Impairment — Recruiting now
• Targeting Endoplasmic Reticulum Stress in Human Hypertension — Recruiting now
• PRECISION Pain Research Registry — Recruiting now
• TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment — Completed
• TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection — Completed
• Heat Therapy, Functional Capacity, and Vascular Health in Older Adults — Completed
• A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam) — Running, not enrolling
• Enhancing Quality in Protective Strategies — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI) — Stopped early
• Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function — Stopped early
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
• Parental Research on Interventions for Social Media — Completed
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection — Completed
• Strategic Timing of Antiretroviral Treatment — Completed
• Pulsatile Perfusion Therapy Phase II — Completed
• Family Health History in Diverse Care Settings (FHH) — Completed
• SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study — Completed
• Exercise in Adults With Mild Memory Problems — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• Optimizing Chronic Pain Management Through Patient Engagement With Quality of Life Measures — Completed
• Health and Aging Brain Study: Health Disparities Tau Positron Emission Tomography (PET) Scan Study — Status unconfirmed
• Effects of OMT on Gait Kinematics and Postural Control in Parkinson Disease — Completed
• Effect of Palpatory Neuromodulation of the Trigeminal Nerve for Tenderness in the Posterior Neck Musculature — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis — Completed
• Quality of Life in Managing Chronic Pain — Completed
• Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202) — Completed
• The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment — Completed
• Osteopathic Manipulative Medicine in Pregnancy: Physiologic and Clinical Effects — Completed
• SHE Tribe: An Intervention to Improve Health Behavior Among Women in Underserved Communities — Status unconfirmed
• Respiratory Virus Outpatient Study (FLU 002 Plus) — Completed
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed
• Collection of Blood Samples From SMART Study Participants for Future Genetic Studies — Completed
• Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects — Withdrawn before enrolling
• OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus — Stopped early
• Motivational Assessment Program to Initiate Treatment — Completed
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz — Completed
• TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment — Completed
• TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance — Completed
• TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment — Completed
• TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment — Completed
• RLIP76 in Human Serum in Adults With Rheumatologic Diseases — Withdrawn before enrolling
• Amphotericin B Suspension in Refractory Chronic Sinusitis — Completed
• TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment — Completed
• TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB — Completed
• TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine — Completed
• TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis — Completed
• TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis — Completed